Clive Dix is used to sorting out complicated challenges. He has founded and run several biotechs in his time and has a broad knowledge of the scientific and commercial landscapes of a variety of therapeutic areas. But he really found himself in the eye of the storm when in 2020 he was appointed deputy chair of the UK’s Vaccine Taskforce to help lead efforts to find and manufacture a coronavirus vaccine. The government established the Taskforce in March 2020, and it reported directly to the Business Secretary. Dame Kate Bingham was appointed the Taskforce’s chair in May 2020, and Dix later stepped up to lead as interim chair for a period in early 2021 after she stood down.
Dix, who holds a degree and a PhD in pharmacology, is currently executive chair of C4X Discovery Holdings plc, as well as chair of UK biotech companies Touchlight Genetics...
He grew up with a fascination for biology and was encouraged by his father from a young age to pursue this interest. Dix recalled in an exclusive interview with In...
